About this trial
This randomized clinical trial aims to evaluate the clinical effectiveness of a remineralizing self-etch primer used for orthodontic bracket bonding. The study compares bonding performance, enamel surface effects, and clinical outcomes between the experimental primer and the conventional bonding protocol,verify the potential remineralization effect, and examine the amount of adhesive remnants left on enamel over a period of 6 months.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Full permanent dentition including incisors, canines, premolars, and molars (excepting 3rd molars;
Teeth with sound, non-carious buccal enamel and no pretreatment with chemical agents such as hydrogen peroxide,
No previous orthodontic treatment with fixed appliances.
Disqualifiers
Participants unable to give informed consent,
Had craniofacial anomalies,
Require orthognathic surgery as part of their treatment,
Had congenital enamel defects.
Trial design
Parallel
Treatments tested in this trial
Remineralizing self-etch primer (M-SEP, SEP 1)
DeviceExperimental self-etch primer based on Transbond Plus modified with 7% nano-hydroxyapatite. Applied to labial/buccal enamel of incisors, canines, and premolars after pumice prophylaxis; air-dried 3 s, brackets bonded with Transbond XT and LED light-cured 10 s mesial and 10 s distal.
Standard self-etch primer (P-SEP, SEP 2)
DeviceConventional Transbond Plus self-etch primer used according to manufacturer's instructions for enamel conditioning of incisors, canines, and premolars, followed by Transbond XT adhesive and LED light-curing as above.
Treatment groups
Trial outcomes
Primary outcomes
Bracket Bond Failure Rate
Documented as a percentage of brackets debonded during the 6-month observation period, categorized by location (incisor, canine, premolar) and cause (adhesive failure, cohesive failure, bracket fracture .
Secondary outcomes
Adhesive Remnant Index
Adhesive Remnant Index (ARI) scores will be assessed to determine failure mode
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: